Atracurium Besylate Injection 10mg/ml

Krajina: Arménsko

Jazyk: angličtina

Zdroj: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktívna zložka:

atracurium (atracurium besylate)

Dostupné z:

Swiss Parenterals Pvt. Ltd.

INN (Medzinárodný Name):

atracurium (atracurium besylate)

Dávkovanie:

10mg/ml

Forma lieku:

solution for injection

Typ predpisu:

Prescription

Súhrn charakteristických

PRODUCT NAME: ATRACURIUM BESYLATE INJECTION 10 MG/ML, 2.5 ML
DOSAGE FORM: SOLUTION FOR INJECTION
_ _
_ _
_Confidential _
1.
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Atracurium Besylate Injection 10 mg/ml, 2.5 ml
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
QUALITATIVE DECLARATION
Atracurium Besylate Injection 10 mg/ml, 2.5 ml
QUANTITATIVE DECLARATION
Each ml contains:
Atracurium Besylate 10 mg
Water for Injections q.s.
DESCRIPTION
Atracurium
Besylate
Injection
is
clear,
colourless
solution
filled
in
a
glass
ampoule.
Atracurium
besylate
is
designated
as
Isoquinolinium,
2,2-[1,5-
pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-imethoxyphenyl)methyl]-
1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate.
-
INN Name is Atracurium Besylate.
PHARMACOLOGIC CLASSIFICATION: Nondepolarizing neuromuscular blocker
THERAPEUTIC CLASSIFICATION: Skeletal muscle relaxant
3.
PHARMACEUTICAL FORM
Sterile Solution for Injection
PRODUCT NAME: ATRACURIUM BESYLATE INJECTION 10 MG/ML, 2.5 ML
DOSAGE FORM: SOLUTION FOR INJECTION
_ _
_ _
_Confidential _
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Atracurium Besylate Injection is a highly selective, competitive or
non-depolarising
neuromuscular blocking agent, which is used as an adjunct to general
anaesthesia to
enable tracheal intubation to be performed and to relax skeletal
muscles during surgery or
controlled ventilation.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
INJECTION:
Atracurium Besylate Injection is administered by intravenous
injection. The dosage range
for adults is 0.3 to 0.6 mg/kg (depending on the duration of full
block required) and will
provide adequate relaxation for 15 to 35 minutes.
Endotracheal
intubation
can
usually
be
accomplished
within
90
seconds
from
the
intravenous injection of 0.5 to 0.6 mg/kg.
Full block can be prolonged with supplementary doses of 0.1 to 0.2
mg/kg as required.
Successive supplementary dosing does not give rise to accumulation of
neuromuscular
blocking effect.
CONTINUOUS INFUSION:
NORMOTHERMIA: